News

The company has also received another $5m milestone payment, which was triggered by the European Medicines Agency (EMA) acceptance of the marketing authorization application. Peginesatide is currently under

The study has met its objective of establishing bioequivalence to Zofran, the current approved reference listed drug. RedHill expects to file an application with the FDA for US

The study data demonstrated that CF101 is efficacious in preventing the clinical manifestations of Anterior Uveitis in an animal model. The study data support the utilization of CF101

Terms of the purchase have not been disclosed. Sigma-Aldrich expects this acquisition to be neutral to earnings per share in 2012. Research Organics will undergo transition into SAFC,

EXPAREL is indicated for administration into the surgical site to produce postsurgical analgesia. The product combines bupivacaine with DepoFoam, a product delivery technology that delivers medication over a

MDA translational research director Jane Larkindale said the grant will help to support further testing of CAT-1004 to assess the compound’s ability to counter muscle-damaging inflammation and support

The system was found to be more viable and affordable to the industry, the Pharmabiz reported. The task force was set up by the government in 2011 to

The DDA has invited all drug companies to register under WHO-GMP within mid-April 2012, The Himalayan Times reported. With the introduction of the norms, it will be obligatory

The line consists of ALARM Pre-Workout, DEXYFEN Fat Loss Formula, TEST 7 PCT Testosterone Booster, TROPINEX AQ Growth Releasing Peptide Formula, SAAs with ENERGY, VEIN Muscle Fullness Response,